Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies
Pediatric-onset multiple sclerosis (POMS) refers to multiple sclerosis occurring in individuals under 18 years of age. It is characterized by poor cognitive outcomes and a more inflammatory course, more frequent clinical relapses, and a greater number of MRI lesions compared to adult-onset MS (AOMS)...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-07-01
|
| Serier: | Neurotherapeutics |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1878747925001096 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|